AVANT BRANDS INC (AVNT.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:AVNT - CA05353D2023 - Common Stock
0.95 CAD
+0.02 (+2.15%)
Taking everything into account, AVNT scores 2 out of 10 in our fundamental rating. AVNT was compared to 32 industry peers in the Pharmaceuticals industry. AVNT has a bad profitability rating. Also its financial health evaluation is rather negative. AVNT does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year AVNT has reported negative net income.
In the past year AVNT had a positive cash flow from operations.
AVNT had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: AVNT reported negative operating cash flow in multiple years.
1.2 Ratios
AVNT has a Return On Assets of -40.53%. This is in the lower half of the industry: AVNT underperforms 78.13% of its industry peers.
With a Return On Equity value of -74.11%, AVNT is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
AVNT has a Return On Invested Capital of 1.44%. This is in the better half of the industry: AVNT outperforms 65.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -40.53% | ||
| ROE | -74.11% | ||
| ROIC | 1.44% |
ROA(3y)-18.44%
ROA(5y)-20.49%
ROE(3y)-32.03%
ROE(5y)-31.07%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AVNT has a better Operating Margin (1.99%) than 65.63% of its industry peers.
AVNT has a Gross Margin (30.58%) which is in line with its industry peers.
In the last couple of years the Gross Margin of AVNT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.99% | ||
| PM (TTM) | N/A | ||
| GM | 30.58% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.97%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
AVNT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AVNT has been increased compared to 1 year ago.
The number of shares outstanding for AVNT has been reduced compared to 5 years ago.
Compared to 1 year ago, AVNT has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -1.41, we must say that AVNT is in the distress zone and has some risk of bankruptcy.
AVNT's Altman-Z score of -1.41 is on the low side compared to the rest of the industry. AVNT is outperformed by 62.50% of its industry peers.
AVNT has a debt to FCF ratio of 6.46. This is a slightly negative value and a sign of low solvency as AVNT would need 6.46 years to pay back of all of its debts.
AVNT has a Debt to FCF ratio of 6.46. This is in the better half of the industry: AVNT outperforms 71.88% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that AVNT is not too dependend on debt financing.
AVNT has a Debt to Equity ratio (0.38) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 6.46 | ||
| Altman-Z | -1.41 |
ROIC/WACC0.19
WACC7.74%
2.3 Liquidity
AVNT has a Current Ratio of 1.63. This is a normal value and indicates that AVNT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.63, AVNT is in line with its industry, outperforming 50.00% of the companies in the same industry.
A Quick Ratio of 0.85 indicates that AVNT may have some problems paying its short term obligations.
AVNT's Quick ratio of 0.85 is on the low side compared to the rest of the industry. AVNT is outperformed by 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.63 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
The earnings per share for AVNT have decreased strongly by -22.18% in the last year.
AVNT shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.36%.
The Revenue has been growing by 72.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.18%
Revenue 1Y (TTM)26.36%
Revenue growth 3Y55.63%
Revenue growth 5Y72.25%
Sales Q2Q%11.19%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
AVNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
93.75% of the companies in the same industry are more expensive than AVNT, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, AVNT is valued cheaper than 96.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.63 | ||
| EV/EBITDA | 4.79 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for AVNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:AVNT (12/24/2025, 7:00:00 PM)
0.95
+0.02 (+2.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.22%
Ins Owner ChangeN/A
Market Cap10.84M
Revenue(TTM)37.49M
Net Income(TTM)-20.02M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.29 | ||
| P/FCF | 4.63 | ||
| P/OCF | 4.46 | ||
| P/B | 0.4 | ||
| P/tB | 0.42 | ||
| EV/EBITDA | 4.79 |
EPS(TTM)-1.96
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.21
FCFY21.61%
OCF(TTM)0.21
OCFY22.45%
SpS3.29
BVpS2.37
TBVpS2.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -40.53% | ||
| ROE | -74.11% | ||
| ROCE | 2% | ||
| ROIC | 1.44% | ||
| ROICexc | 1.48% | ||
| ROICexgc | 1.52% | ||
| OM | 1.99% | ||
| PM (TTM) | N/A | ||
| GM | 30.58% | ||
| FCFM | 6.25% |
ROA(3y)-18.44%
ROA(5y)-20.49%
ROE(3y)-32.03%
ROE(5y)-31.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.97%
GM growth 5Y-0.04%
F-Score3
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 6.46 | ||
| Debt/EBITDA | 1.99 | ||
| Cap/Depr | 2.04% | ||
| Cap/Sales | 0.24% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 46.72% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.63 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | -1.41 |
F-Score3
WACC7.74%
ROIC/WACC0.19
Cap/Depr(3y)30.6%
Cap/Depr(5y)37.88%
Cap/Sales(3y)6.99%
Cap/Sales(5y)7.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.36%
Revenue growth 3Y55.63%
Revenue growth 5Y72.25%
Sales Q2Q%11.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y778.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y156.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43.1%
OCF growth 3YN/A
OCF growth 5YN/A
AVANT BRANDS INC / AVNT.CA FAQ
What is the fundamental rating for AVNT stock?
ChartMill assigns a fundamental rating of 2 / 10 to AVNT.CA.
What is the valuation status of AVANT BRANDS INC (AVNT.CA) stock?
ChartMill assigns a valuation rating of 2 / 10 to AVANT BRANDS INC (AVNT.CA). This can be considered as Overvalued.
How profitable is AVANT BRANDS INC (AVNT.CA) stock?
AVANT BRANDS INC (AVNT.CA) has a profitability rating of 2 / 10.